Successful transformation to CDMO
Over the last two years a significant and highly successful transformation has taken place at the Skyepharma site in Lyon, France.
The mission has been to transform the site into an end-to-end contract development and manufacturing organisation (CDMO) with services extending from early stage development and manufacturing through to packaging, serialisation and aggregation included .
The journey began in July 2016 and has been organised around four core strands of activity – culture change, pharmaceutical development growth, strong investments in industrial equipment and business development.
David Lescuyer’s testimony
David Lescuyer, President of Skyepharma tells about our journey to be a CDMO in the interview by PharmaBoardRoom : Click here to read the interview.